Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 13, 2026
TickeronGET DAILY SIGNALS
Why Is Owlet, Inc. (OWLT) Stock Down -35.71% Today?

Why Is Owlet, Inc. (OWLT) Stock Down -35.71% Today?

Key Takeaways

  • Owlet, Inc. (OWLT) shares fell 35.71% to $2.97 in intraday trading, down $1.65 from the prior close of $4.62.
  • The primary catalyst was the company's third-quarter 2026 report, which paired a modest revenue decline with a voluntary camera cable guard safety update.
  • Owlet withdrew its previously issued full-year 2026 financial outlook, eliminating the company's own guidance just as the holiday selling season begins.
  • Secondary pressure came from a 12% decline in hardware revenue, aggressive competitor discounting, and a revision of prior-period financial statements tied to overstated stock-based compensation.
  • Small-caps and retail broadly traded near flat, so the plunge was company-specific rather than sector-driven.
  • News Significance Score: 85/100 – Major verified news, including withdrawn guidance, combined with a move roughly 14 times the stock's typical daily swing.
  • Traders will watch replacement-unit shipping costs, retailer returns, insurance recovery, and any reinstated outlook.
  • Explore Price Targets, Earnings, and Forecast data for deeper context on where the shares may be headed.
  • For systematic, rules-based exposure ideas, review the curated Trending AI Robots list.

Opening Summary

Owlet, Inc. (OWLT) is a Lehi, Utah-based pediatric health platform that sells FDA-cleared wearable infant monitors, camera systems, and the Owlet360 subscription service. In intraday trading on November 13, 2026, the stock fell 35.71% to $2.97, down from a prior close of $4.62 — a decline of $1.65 per share. The move was clearly to the downside and erased more than a third of the company's market value in a single session. The immediate cause was verified: Owlet's third-quarter results, released before the open, included the withdrawal of full-year 2026 guidance and a voluntary safety update for the cable guard accessory sold with its cameras.

Earnings Beat Overshadowed by Safety Remediation

The quarter itself was not the problem. Revenue of $30.4 million slipped 4.9% from $32.0 million a year earlier but landed within 1% of consensus. Adjusted earnings of $0.11 per share far exceeded expectations for a small loss, gross margin expanded 315 basis points to 53.8%, and adjusted EBITDA reached a record $3.5 million. Subscription revenue more than doubled to $3.6 million, with paying Owlet360 subscribers up 83% year over year to over 142,000.

What broke the narrative was the accompanying safety notice. After a report that a toddler became entangled in an unsecured camera cable, Owlet began shipping a replacement enclosed cable guard system free of charge to every camera owner who requests one. Management estimated $7 million to $10 million in direct program costs — production, logistics, customer support, legal and consulting — plus $9 million to $12 million in retailer returns recorded as revenue reductions. Partial offsets include $3 million to $4 million of resellable returned inventory, $2 million to $5 million in replenishment load-in, and up to $10 million of potential insurance recovery that is not guaranteed. The issue is confined to the camera accessory and does not affect Dream Sock monitoring.

Guidance Withdrawal Removes the Anchor

Citing the stop-sale, the returns process, and near-term demand uncertainty, Owlet pulled its full-year 2026 outlook and offered no replacement range. Management said the business had been on track to reaffirm its forecast before the safety update, but the spread of possible fourth-quarter outcomes became too wide to project responsibly. For investors, the loss of guidance is the most damaging element: it arrives in the company's most important selling quarter and leaves no company-defined benchmark against consensus estimates of roughly $122 million in full-year revenue and $34 million in the fourth quarter.

Hardware Pressure and an Accounting Revision

Hardware revenue fell 12% to $26.8 million, reflecting the lapping of the prior-year Dream Sight launch and aggressive competitor discounting ahead of Amazon's August 2026 FDA-clearance enforcement deadline. Owlet also revised previously issued financial statements for the first quarter of 2026 and prior periods to correct overstated stock-based compensation from employee stock purchase plan valuation errors. The revision was deemed immaterial, but it adds noise to comparisons at a moment when credibility matters.

Market Context and Trading Activity

Volume was exceptionally heavy. Roughly 99,000 shares changed hands in the first 15 minutes of the session — about half of the stock's average full-day turnover of some 188,000 shares — putting the day on pace for multiples of normal activity. The selling was purely idiosyncratic: the small-cap benchmark traded slightly lower while the retail sector ETF edged higher, and there was no comparable stress among consumer hardware or pediatric health peers.

Technically, the damage is severe. Shares opened at $2.99 and printed a low of $2.87, slicing through the prior 52-week floor near $4.03 and breaking well below the $4.20–$4.60 range that had contained trading through October and early November. The stock sits far under its September levels above $5, and the gap-down leaves a large unfilled chart void overhead.

News Significance Score

The scale runs from 0, meaning no meaningful news and a normal move for the stock, to 100, meaning transformative news and an extreme, rare price move. Owlet earns 85 out of 100.

The verified news was substantial relative to a company of this size: guidance withdrawn outright, a product safety program with remediation and returns costs equal to more than 15% of annual revenue, and a restatement of prior periods. The price move was close to 14 times the stock's average absolute daily change of about 2.6% over the past 60 sessions, and no session in that window came close to a 35% swing — the largest was roughly 11%. Major news plus a near-unprecedented move produces the high score.

What Comes Next for OWLT

Attention now shifts to the mechanics of the safety program: how many camera owners request replacement guards, how quickly retailer returns are processed, and whether the insurance recovery materializes. Owlet ended the quarter with $31.6 million in cash and roughly $39.5 million of total liquidity, which management frames as sufficient to absorb the costs while funding product work — including the newly launched Smart Thermometer, the Owlet OnCall telehealth rollout expected in late 2026 and early 2027, and the OwletOne bundle now in testing. Analysts will look for any reinstated guidance, fourth-quarter sell-through data during the holiday period, subscription churn trends, and clarification of liability exposure. The central uncertainty is whether the fourth-quarter disruption proves a one-time event or signals lasting damage to retail relationships and demand.

Trending AI Robots

Tickeron's Trending AI Robots page curates the platform's strongest-performing trading bots under current market conditions, drawn from a library of hundreds of algorithms spanning thousands of tickers. Bots differ widely by strategy, timeframe, performance metrics, and the symbols they trade, so the featured group rotates as conditions change. For investors navigating volatile single-name moves like this one, the page offers a structured way to see which automated strategies are working right now — and a sensible starting point for building a watchlist.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: OWLT

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


OWLT's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for OWLT turned positive on November 02, 2026. Looking at past instances where OWLT's MACD turned positive, the stock continued to rise in 39 of 44 cases over the following month. The odds of a continued upward trend are 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for OWLT's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

Following a +6.45% 3-day Advance, the price is estimated to grow further. Considering data from situations where OWLT advanced for three days, in 209 of 244 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

OWLT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Momentum Indicator moved below the 0 level on November 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on OWLT as a result. In 73 of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OWLT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for OWLT entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 16 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.847) is normal, around the industry mean (4.142). P/E Ratio (-13.900) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (0.967) is also within normal values, averaging (40.124).

The Tickeron PE Growth Rating for this company is 16 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 75 (best 1 - 100 worst), indicating slightly worse than average price growth. OWLT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OWLT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Medtronic plc (NYSE:MDT), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW).

Industry description

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

Market Cap

The average market capitalization across the Medical/Nursing Services Industry is 6.17B. The market cap for tickers in the group ranges from 837 to 190.22B. ABT holds the highest valuation in this group at 190.22B. The lowest valued company is DHAI at 837.

High and low price notable news

The average weekly price growth across all stocks in the Medical/Nursing Services Industry was 1%. For the same Industry, the average monthly price growth was -4%, and the average quarterly price growth was -6%. POAS experienced the highest price growth at 351%, while NPCE experienced the biggest fall at -40%.

Volume

The average weekly volume growth across all stocks in the Medical/Nursing Services Industry was 27%. For the same stocks of the Industry, the average monthly volume growth was 23% and the average quarterly volume growth was 12%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 48
P/E Growth Rating: 49
Price Growth Rating: 61
SMR Rating: 89
Profit Risk Rating: 94
Seasonality Score: 13 (-100 ... +100)
Paper Trades 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry MedicalNursingServices

Industry
N/A
Address
2940 West Maple Loop Drive
Phone
+1 844 334-5330
Employees
114
Web
https://www.owletcare.com
Interact to see
Advertisement
AMD fell -5.03% to $555.85 in regular-session trading Friday, down -$29.45 from Thursday's close of $585.30, as of 9:42 a.m. ET shortly after the opening bell. No verified company-specific news or fundamental catalyst found: the decline tracks a broad semiconductor pullback and is consistent with profit-taking after a +44.7% rebound from the Nov. 5 close of $404.40, with the stock's typical daily swing running at 3.6%.
BZ dropped sharply, sliding from a $16.72 prior close to $13.48 (-19.38%), with the decline beginning in premarket and deepening into the early regular session. No verified company-specific news or fundamental catalyst was issued; the fall tracked a broad China ADR selloff (the Nasdaq Golden Dragon index slid more than 2%), but that alone is too small to explain a ~20% drop — the stock's Hong Kong listing fell only -2.6%.
NBIS fell from $154.69 to $129.12, down -16.53%, with the decline starting in premarket trading and continuing through the regular session. The drop followed Q3 results: revenue of $980.8M (+571% YoY) beat estimates, but management cut 2026 revenue guidance to the low end of its range on third-party capacity delays and raised 2026 capex to roughly $27B, reviving financing and execution fears.
The $290 central target is the arithmetic mean of 12 verified analyst price targets (rounded from roughly $293), with a wide range of about $126 to $410. Shares traded near $155 on the eve of the third-quarter report before falling roughly 17% to 22% after full-year guidance disappointed, widening the gap to the target.
IREN dropped -7.58% during regular trading, sliding from a $20.84 prior close to $19.26. A broad AI/neocloud sector sell-off drove the decline, after a Reuters report raised concerns over Nvidia CEO Jensen Huang's leadership and Nebius guided its 2026 revenue toward the low end of its range.
Why Is Owlet, Inc. (OWLT) Stock Down -35.71% Today?